Oncologic Outcomes in Nipple-sparing Mastectomy with Immediate Reconstruction and Total Mastectomy with Immediate Reconstruction in Women with Breast Cancer: A Machine-Learning Analysis

Overview

Journal Ann Surg Oncol

Publisher Springer

Specialty Oncology

Date 2023 Aug 16

PMID 37587360

Authors

Jun-Ho Cho

Jung Mi Park

Hyung Seok Park

Hye Jin Kim

Dong-Min Shin

Jee Ye Kim

Seho Park

Seung Il Kim

Byeong-Woo Park

Affiliations

Soon will be listed here.

Abstract

Background: This study used a single-institution cohort, the Severance dataset, validated the results by using the surveillance, epidemiology, and end results (SEER) database, adjusted with propensity-score matching (PSM), and analyzed by using a machine learning method. To determine whether the 5-year, disease-free survival (DFS) and overall survival (OS) of patients undergoing nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) are not inferior to those of women treated with total mastectomy/skin-sparing mastectomy (TM/SSM).

Methods: The Severance dataset enrolled 611 patients with early, invasive breast cancer from 2010 to 2017. The SEER dataset contained data for 485,245 patients undergoing TM and 14,770 patients undergoing NSM between 2000 and 2018. All patients underwent mastectomy and IBR. Intraoperative, frozen-section biopsy for the retro-areolar tissue was performed in the NSM group. The SEER dataset was extracted by using operation types, including TM/SSM and NSM. The primary outcome was DFS for the Severance dataset and OS for the SEER dataset. PSM analysis was applied. Survival outcomes were analyzed by using the Kaplan-Meier method and Cox proportional hazard (Cox PH) regression model. We implemented XGBSE to predict mortality with high accuracy and evaluated model prediction performance using a concordance index. The final model inspected the impact of relevant predictors on the model output using shapley additive explanation (SHAP) values.

Results: In the Severance dataset, 151 patients underwent NSM with IBR and 460 patients underwent TM/SSM with IBR. No significant differences were found between the groups. In multivariate analysis, NSM was not associated with reduced oncologic outcomes. The same results were observed in PSM analysis. In the SEER dataset, according to the SHAP values, the individual feature contribution suggested that AJCC stage ranks first. Analyses from the two datasets confirmed no impact on survival outcomes from the two surgical methods.

Conclusions: NSM with IBR is a safe and feasible procedure in terms of oncologic outcomes. Analysis using machine learning methods can be successfully applied to identify significant risk factors for oncologic outcomes.

Citing Articles

Long-term outcomes of skin-sparing mastectomy and nipple-sparing mastectomy versus traditional mastectomy in breast cancer: a case-control study based on preoperative ultrasound and clinical indicators.

Si M, Jiao Y, Xu L, Lin R, Zhong X, Lv Q World J Surg Oncol. 2025; 23(1):52.

PMID: 39953494 PMC: 11827176. DOI: 10.1186/s12957-025-03695-4.

References

FREEMAN B . Subcutaneous mastectomy for benign breast lesions with immediate or delayed prosthetic replacement. Plast Reconstr Surg Transplant Bull. 1962; 30:676-82. DOI: 10.1097/00006534-196212000-00008. View

Toth B, Lappert P . Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning. Plast Reconstr Surg. 1991; 87(6):1048-53. View

Agha R, Al Omran Y, Wellstead G, Sagoo H, Barai I, Rajmohan S . Systematic review of therapeutic nipple-sparing skin-sparing mastectomy. BJS Open. 2019; 3(2):135-145. PMC: 6433323. DOI: 10.1002/bjs5.50119. View

Bailey C, Ogbuagu O, Baltodano P, Simjee U, Manahan M, Cooney D . Quality-of-Life Outcomes Improve with Nipple-Sparing Mastectomy and Breast Reconstruction. Plast Reconstr Surg. 2017; 140(2):219-226. DOI: 10.1097/PRS.0000000000003505. View

Sherman K, Woon S, French J, Elder E . Body image and psychological distress in nipple-sparing mastectomy: the roles of self-compassion and appearance investment. Psychooncology. 2016; 26(3):337-345. DOI: 10.1002/pon.4138. View

Gerber B, Krause A, Dieterich M, Kundt G, Reimer T . The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg. 2009; 249(3):461-8. DOI: 10.1097/SLA.0b013e31819a044f. View

Peled A, Duralde E, Foster R, Stover Fiscalini A, Esserman L, Hwang E . Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction. Ann Plast Surg. 2013; 72 Suppl 1:S48-52. DOI: 10.1097/SAP.0000000000000020. View

Mota B, Riera R, Ricci M, Barrett J, de Castria T, Atallah A . Nipple- and areola-sparing mastectomy for the treatment of breast cancer. Cochrane Database Syst Rev. 2016; 11:CD008932. PMC: 5868722. DOI: 10.1002/14651858.CD008932.pub3. View

Han W, Lee H . Recurrence at the Nipple-Areola Complex and Safety of Nipple-Sparing Mastectomy. JAMA Surg. 2020; 155(4):364-365. DOI: 10.1001/jamasurg.2019.5477. View

10.

Conde D, Torresan R . Nipple-sparing mastectomy: what is the frontier between oncologic safety and cosmetic outcome?. J Plast Reconstr Aesthet Surg. 2013; 66(5):734-5. DOI: 10.1016/j.bjps.2012.12.014. View

11.

De La Cruz L, Moody A, Tappy E, Blankenship S, Hecht E . Overall Survival, Disease-Free Survival, Local Recurrence, and Nipple-Areolar Recurrence in the Setting of Nipple-Sparing Mastectomy: A Meta-Analysis and Systematic Review. Ann Surg Oncol. 2015; 22(10):3241-9. DOI: 10.1245/s10434-015-4739-1. View

12.

Benediktsson K, Perbeck L . Survival in breast cancer after nipple-sparing subcutaneous mastectomy and immediate reconstruction with implants: a prospective trial with 13 years median follow-up in 216 patients. Eur J Surg Oncol. 2007; 34(2):143-8. DOI: 10.1016/j.ejso.2007.06.010. View

13.

Wu Z, Kim H, Lee J, Chung I, Kim J, Lee S . Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant Chemotherapy. JAMA Surg. 2020; 155(12):1142-1150. PMC: 7557719. DOI: 10.1001/jamasurg.2020.4132. View

14.

Kim H, Park E, Lim W, Seo J, Koh B, Lee T . Nipple areola skin-sparing mastectomy with immediate transverse rectus abdominis musculocutaneous flap reconstruction is an oncologically safe procedure: a single center study. Ann Surg. 2010; 251(3):493-8. DOI: 10.1097/SLA.0b013e3181c5dc4e. View

15.

Headon H, Kasem A, Mokbel K . The Oncological Safety of Nipple-Sparing Mastectomy: A Systematic Review of the Literature with a Pooled Analysis of 12,358 Procedures. Arch Plast Surg. 2016; 43(4):328-38. PMC: 4959975. DOI: 10.5999/aps.2016.43.4.328. View

16.

Weissler E, Naumann T, Andersson T, Ranganath R, Elemento O, Luo Y . The role of machine learning in clinical research: transforming the future of evidence generation. Trials. 2021; 22(1):537. PMC: 8365941. DOI: 10.1186/s13063-021-05489-x. View

17.

Zhang M . Cox proportional hazards regression models for survival data in cancer research. Cancer Treat Res. 2003; 113:59-70. DOI: 10.1007/978-1-4757-3571-0_4. View

18.

Won S, Park H, Kim E, Kim S, Moon H, Yoon J . Survival Rates of Breast Cancer Patients Aged 40 to 49 Years according to Detection Modality in Korea: Screening Ultrasound versus Mammography. Korean J Radiol. 2020; 22(2):159-167. PMC: 7817635. DOI: 10.3348/kjr.2019.0588. View

19.

Sihag S, Nobel T, Hsu M, De La Torre S, Tan K, Janjigian Y . Survival After Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?. Ann Surg. 2020; 276(6):1017-1022. PMC: 8126574. DOI: 10.1097/SLA.0000000000004638. View

20.

Paepke S, Schmid R, Fleckner S, Paepke D, Niemeyer M, Schmalfeldt B . Subcutaneous mastectomy with conservation of the nipple-areola skin: broadening the indications. Ann Surg. 2009; 250(2):288-92. DOI: 10.1097/SLA.0b013e3181b0c7d8. View